THE SIGNIFICANCE OF THE HIV RESISTANCE ANALYSIS IN ANTIRETROVIRAL THERAPY

THE SIGNIFICANCE OF THE HIV RESISTANCE ANALYSIS IN ANTIRETROVIRAL THERAPY

.

Bibliographic Details
Main Authors:	D. E. Valutite, Yu. V. Ostankova
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2018-12-01
Series:	Инфекция и иммунитет
Online Access:	https://www.iimmun.ru/iimm/article/view/1073

Similar Items

THE PREVALENCE OF HIV-1 DRUG RESISTANCE MUTATIONS IN PATIENTS WITH LOW ADHERENCE TO ANTIRETROVIRAL THERAPY IN THE LENINGRAD REGION
by: A. N. Shchemelev, et al.
Published: (2018-12-01)

Cases inefficient antiretroviral therapy for HIV-1 in children
by: Yu. V. Ostankova, et al.
Published: (2017-06-01)

Determination of HIV Tropism in Patients with Antiretroviral Therapy Failure in Arkhangelsk Region
by: Yu. V. Ostankova, et al.
Published: (2022-10-01)

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
by: D. E. Valutite, et al.
Published: (2018-12-01)

HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam.
by: Thao, V, et al.
Published: (2012)

The Russian database of HIV antiretroviral drug resistance
by: Dmitry E. Kireev, et al.
Published: (2023-05-01)

Genetic diversity and drug resistance mutations of HIV-1 in Leningrad Region
by: A. N. Shchemelev, et al.
Published: (2022-03-01)

Primary HCV Drug Resistance Mutations in Patients with Newly Diagnosed HIV Infection
by: Yu. V. Ostankova, et al.
Published: (2020-10-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
by: V. B. Denisenko, et al.
Published: (2018-07-01)

THE SAFETY OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN HIV POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
by: S. Yu. Degtyareva, et al.
Published: (2019-04-01)

Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan
by: Ainur Mukhatayeva, et al.
Published: (2022-10-01)

THE DRUG RESISTANCE MUTATIONS OF THE HEPATITIS B VIRUS AMONG HIV-INFECTED INDIVIDUALS
by: Yu. V. Ostankova
Published: (2018-12-01)

HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam (vol 17, pg 905, 2012)
by: Thao, V, et al.
Published: (2012)

HEPATITIS B VIRUS IDENTIFICATION IN THE ENSURING INFECTIOUS SAFETY OF BLOOD TRANSFUSIONS
by: Yu. V. Ostankova, et al.
Published: (2018-12-01)

Psychological problems of HIV-infected patients in preparing to the start of antiretroviral therapy
by: O. V. Koltsova, et al.
Published: (2019-12-01)

Ethambutol Toxicity in HIV Patients on Antiretroviral Therapy
by: K K Vyas, J P S Nalva
Published: (2023-10-01)

Monitoring of highly active antiretroviral therapy in HIV infection.
by: Walker, A, et al.
Published: (2011)

HIV-1 subtypes and drug-resistance mutation sites in HIV/AIDS patients with antiretroviral-therapy failure
by: LIN Junxiao, et al.
Published: (2023-03-01)

Negative effect of antiretroviral therapy on spermogram values in HIV-positive men
by: E. V. Mityurina, et al.
Published: (2019-04-01)

HIV INTEGRASE INHIBITORS: THE BASIS OF EFFECTIVE AND SAFE ANTIRETROVIRAL THERAPY
by: V. I. SHAKHGILDYAN
Published: (2017-05-01)

Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
by: Hakim, J, et al.
Published: (2017)

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naive HIV-1 infected patients in Greece.
by: Magiorkinis, E, et al.
Published: (2002)

EFFICACY OF ANTIRETROVIRAL THERAPY IN PATIENTS IN THE LATE STAGE HIV INFECTION
by: E.R. RAKHMANOV, et al.
Published: (2019-06-01)

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
by: Inzaule, S, et al.
Published: (2016)

Short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2013)

Antiretroviral therapy and intestinal microsporidiosis in thai HIV infected patients
by: Wiwanitkit V.
Published: (2007-09-01)

HIV infection significantly reduces lipoprotein lipase which remains low after 6 months of antiretroviral therapy
by: Boothby, M, et al.
Published: (2008)

Distribution of Primary Resistance Mutations in Saint Petersburg in Patients with Chronic Hepatitis C
by: Diana Valutite, et al.
Published: (2022-04-01)

How soon after HIV seroconversion is antiretroviral therapy initiated?
by: Babiker, A, et al.
Published: (1999)

Analysis of the prevalence of dyslipidemia in individuals with HIV and its association with antiretroviral therapy
by: Talita Gabriela de Limas, et al.
Published: (2014-10-01)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
by: Foster, C, et al.
Published: (2017)

Current Perspectives on HIV-1 Antiretroviral Drug Resistance
by: Pinar Iyidogan, et al.
Published: (2014-10-01)

Universal voluntary HIV testing and immediate antiretroviral therapy.
by: Jaffe, H, et al.
Published: (2009)

When to start antiretroviral therapy in HIV-associated tuberculosis.
by: Török, M, et al.
Published: (2011)

The moral and fiscal implications of antiretroviral therapies for HIV in Africa
by: Collier, P, et al.
Published: (2018)

HIV-1 protease as a target for antiretroviral therapy
by: Windsor, Ian William.
Published: (2019)

When to start antiretroviral therapy in HIV-infected children
by: Tammy Meyers
Published: (2002-07-01)

HIV‐associated dysbiosis and immune recovery during antiretroviral therapy
by: Samuel D. Johnson, et al.
Published: (2022-04-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
by: Paton, N, et al.
Published: (2014)

Mental health of people living with hiv and adherence to antiretroviral therapy
by: F. Goma, et al.
Published: (2021-04-01)